Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02728258
Title Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors NRG Oncology
Indications

endometrial cancer

Therapies

Copanlisib

Age Groups: adult

Additional content available in CKB BOOST